|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.030 HKD | -0.96% |
|
+0.98% | +28.75% |
| 26/06 | Fusen Pharma Gets Marketing Nod for Influenza Drug in China | MT |
| 19/06 | Fusen Pharma Unit to Raise 300 Million Yuan From State-Owned Investors | MT |
| Market Cap | 66Cr 76Cr 9.71Cr 8.49Cr 7.83Cr 7.22Cr 14Cr 935.34Cr 14Cr 94Cr 37Cr 458.09Cr 36Cr 36Cr 1.58TCr | P/E 2024 |
-2.95x | P/E 2025 | -45.1x |
|---|---|---|---|---|---|
| Enterprise Value | 88Cr 101.83Cr 13Cr 11Cr 10Cr 9.65Cr 18Cr 1.25TCr 19Cr 125.18Cr 49Cr 612.56Cr 49Cr 48Cr 2.11TCr | EV / Sales 2024 |
2.83x | EV / Sales 2025 | 2.76x |
| Free-Float |
26.11% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.96% | ||
| 1 week | +0.98% | ||
| Current month | -3.74% | ||
| 3 months | -17.60% | ||
| 6 months | +37.33% | ||
| Current year | +28.75% |
| 1 week | 1 |  | 1.08 |
| 1 month | 0.85 | | 1.11 |
| Current year | 0.68 | | 1.44 |
| 1 year | 0.3 | | 1.75 |
| 3 years | 0.24 | | 1.75 |
| 5 years | 0.24 | | 3.48 |
| 10 years | 0.24 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 48 | 18/04/2019 |
Zhi Ming Cao
IRC | Investor Relations Contact | 40 | 18/01/2013 |
Yuk Hong Yeung
SEC | Corporate Secretary | 36 | 30/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Kwok Tung Lee
BRD | Director/Board Member | 58 | 15/04/2019 |
Ho Ming Yu
BRD | Director/Board Member | 49 | 30/09/2025 |
Tai Sheng Hou
BRD | Director/Board Member | 63 | 07/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/04/24 | Other | Chairman | 6,50,000 | 0.0867% | ||
| 18/04/24 | Other | Chairman | 2,40,000 | 0.0320% | ||
| 18/04/24 | Other | Chairman | 2,40,000 | 0.0320% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.96% | +0.98% | +202.94% | -24.26% | 9.81Cr | |
| -0.90% | -0.31% | +13.62% | +80.12% | 4.86TCr | |
| -0.23% | -0.63% | +67.00% | +115.81% | 3.57TCr | |
| -0.76% | -1.57% | -3.87% | +37.62% | 1.2TCr | |
| -0.88% | -1.32% | +18.04% | +92.11% | 1.19TCr | |
| +1.31% | +1.90% | +34.67% | +129.06% | 928.98Cr | |
| -0.75% | -0.17% | +18.85% | +36.91% | 695.22Cr | |
| +3.37% | -0.96% | +46.11% | -4.38% | 678.73Cr | |
| -2.25% | -1.40% | +1.39% | +218.40% | 669.75Cr | |
| -9.93% | +5.82% | -22.89% | +16.29% | 680.85Cr | |
| Average | -1.20% | +0.70% | +37.59% | +69.77% | 1.45TCr | |
| Weighted average by Cap. | -0.86% | +0.33% | +26.65% | +86.81% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 33Cr 38Cr 4.81Cr 4.2Cr 3.88Cr 3.58Cr 6.74Cr 463.21Cr 6.89Cr 46Cr 18Cr 226.86Cr 18Cr 18Cr 780.96Cr | 27Cr 32Cr 4.03Cr 3.52Cr 3.25Cr 3Cr 5.65Cr 388.38Cr 5.78Cr 39Cr 15Cr 190.21Cr 15Cr 15Cr 654.81Cr |
| Net income | -19Cr -22Cr -2.79Cr -2.43Cr -2.25Cr -2.07Cr -3.9Cr -268.21Cr -3.99Cr -27Cr -11Cr -131.36Cr -10Cr -10Cr -452.21Cr | -1.18Cr -1.36Cr -17.39L -15.19L -14.02L -12.92L -24.36L -17Cr -24.9L -1.68Cr -65.91L -8.2Cr -65.29L -63.86L -28Cr |
| Net Debt | 37Cr 42Cr 5.42Cr 4.73Cr 4.37Cr 4.03Cr 7.59Cr 521.76Cr 7.76Cr 52Cr 21Cr 255.54Cr 20Cr 20Cr 879.69Cr | 22Cr 26Cr 3.28Cr 2.86Cr 2.64Cr 2.43Cr 4.59Cr 315.4Cr 4.69Cr 32Cr 12Cr 154.47Cr 12Cr 12Cr 531.75Cr |
Employees
1,005
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | HK$1.030 | -0.96% | 25,000 |
| 16/26/16 | HK$1.040 | +2.97% | 16,000 |
| 15/26/15 | HK$1.010 | -2.88% | 3,06,000 |
| 14/26/14 | HK$1.040 | 0.00% | 16,000 |
| 13/26/13 | HK$1.040 | +1.96% | 23,000 |
- Stock Market
- Stocks
- 1652 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
